The global sleep apnea oral appliances market, valued at $516.4 million in 2021, is forecasted to reach $2,337.7 million by 2031, with a 16.3% CAGR. Sleep apnea, a serious disorder causing interrupted breathing during sleep, can lead to various health issues if untreated. Oral appliance therapy, including tongue-stabilizing and mandibular advancement devices, helps treat sleep apnea by clearing airway blockages. Market growth is driven by increasing prevalence of sleep apnea, obesity, and geriatric population, alongside product launches and approvals. For instance, Apnea Sciences launched SnoreRx Plus in April 2020, designed to reduce snoring by maintaining an open airway. Rising obesity rates and aging population further contribute to market expansion.

Know More